The effect of cicloxolone sodium on the replication of vesicular stomatitis virus in BSC-1 cells Free

Abstract

The effect of cicloxolone sodium (CCX) on the replication of vesicular stomatitis virus (VSV) was investigated. The drug was active during all stages of the virus replication cycle, indicating that it does not operate by the specific inhibition of any single essential virus gene product. The drug reduced the number of VSV particles assembled and released by 100- to 1000-fold. Infectious virus yield was reduced 1000- to 10000-fold, giving a 10-fold or greater increase in the particle/p.f.u. ratio. The reduced number of virus particles produced in the presence of CCX results from two superimposed effects: suppression of VSV secondary transcription and viral protein synthesis, and perturbation of virion assembly. The inhibition of VSV assembly is due to impairment of a Golgi apparatus function related to transport of VSV glycoprotein G to the cell surface, and is characterized by accumulation of viral G and M proteins within the cell. Incubation of VSV-infected cells in the presence of two glycosylation inhibitors, tunicamycin and monensin, similarly leads to intracellular accumulation of G and M proteins, suggesting a common mechanism of action affecting VSV virion assembly. The differential effect of CCX concentration on intracellular levels of the L, N and NS proteins was analysed. CCX also possesses a virucidal effect on mature infectious VSV particles in suspension, 300 µ reducing the VSV titre about 10-fold in 24 h at 4 °C or 37 °C. The mode of antiviral activity against VSV is compared with that against herpes simplex virus.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-2-397
1992-02-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/2/JV0730020397.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-2-397&mimeType=html&fmt=ahah

References

  1. Ashburner M., Bonner J. J. 1979; The induction of gene activity by heat shock. Cell 17:241–254
    [Google Scholar]
  2. Boss N. F., Moore D. J., Mollenhaver H. H. 1984; Monsenin-induced swelling of the Golgi apparatus cisternae mediated by a proton gradient. European Journal of Cell Biology 34:1–8
    [Google Scholar]
  3. Csonka G. W., Tyrrell D. A. J. 1984; Treatment of herpes genitalitis with carbenoxolone and cicloxolone creams: a double-blind placebo-controlled clinical trial. British Journal of Venereal Diseases 60:178–181
    [Google Scholar]
  4. Dargan D. J., Subak-Sharpe J. H. 1985; The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. I. Effect on cell growth, virus particles and virus replication. Journal of General Virology 66:1771–1784
    [Google Scholar]
  5. Dargan D. J., Subak-Sharpe J. H. 1986a; The effect of triterpenoid compounds on uninfected and herpes simplex virus–infected cells in culture. II. DNA and protein synthesis, polypeptide processing and transport. Journal of General Virology 67:1831–1850
    [Google Scholar]
  6. Dargan D. J., Subak-Sharpe J. H. 1986b; The antiherpes activity of the triterpenoid compounds carbenoxolone sodium and cicloxo-lone sodium. Journal of Antimicrobial Chemotherapy 18 supplement W 185–200
    [Google Scholar]
  7. Dargan D. J., Subak-Sharpe J. H. 1991; The difference in sensitivity to cicloxolone sodium between herpes simplex virus types 1 and 2 maps to the locations of genes UL22 (gH) and UL44 (gC). Journal of General Virology 72:377–384
    [Google Scholar]
  8. Dargan D. J., Aitken J. D., Subak-Sharpe J. H. 1988; The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. III. Ultrastructural study of virion maturation. Journal of General Virology 69:439–444
    [Google Scholar]
  9. Dargan D. J., Galt C. B., Subak-Sharpe J. H. 1992; The effect of cicloxolone sodium on the replication in cultured cells of adenovirus type 5, reovirus type 3, poliovirus type 1, two bunyaviruses and Semliki Forest virus. Journal of General Virology 73:407–411
    [Google Scholar]
  10. Evans D., Pringle C. R., Szilagyi J. F. 1979; Temperaturesensitive mutants of complementation group E of vesicular stomatitis virus. New Jersey serotype possesses altered NS polypeptides. Journal of Virology 31:325–333
    [Google Scholar]
  11. Freeman G. J., Rose J. K., Clinton G. M., Huang A. S. 1977; RNA synthesis of vesicular stomatitis virus. VII. Complete separation of the mRNAs of vesicular stomatitis virus. Journal of Virology 21:1094–1104
    [Google Scholar]
  12. Galt C., Dargan D. J., Subak-Sharpe J. H. 1990; In vitro studies of the antiviral range of cicloxolone sodium and identification of cell lines tolerant to the drug. Antiviral Chemistry and Chemotherapy 1:115–123
    [Google Scholar]
  13. Gibson R., Leavitt R., Kornfeld S., Schlesinger S. 1978; Synthesis and infectivity of vesicular stomatitis virus containing non-glycosylated G protein. Cell 13:671–679
    [Google Scholar]
  14. Johnson P. C., Schlesinger M. J. 1980; Vesicular stomatitis virus and Sindbis virus glycoprotein transport to the cell surface is inhibited by ionophores. Virology 103:407–424
    [Google Scholar]
  15. Johnson P. A., Everett R. D. 1986; The control of herpes simplex virus type 1 late gene transcription: a ‘TATA-box’/cap site region is sufficient for fully efficient activity. Nucleic Acids Research 14:8247–8264
    [Google Scholar]
  16. Ledger P. W., Tanzer M. L. 1984; Monensin: a perturbant of cellular physiology. Trends in Biochemical Sciences 9:313–314
    [Google Scholar]
  17. Marcus L. P., Engelhardt D. L., Hunt J. M., Sekellick M. J. 1971; Interferon action: inhibition of vesicular stomatitis virus RNA synthesis induced by virion-bound polymerase. Science 174:593–598
    [Google Scholar]
  18. Marsden H. S., Crombie I. K., Subak-Sharpe J. H. 1976; Control of protein synthesis in herpesvirus-infected cells: analysis of the polypeptides induced by wild-type and sixteen temperature-sensitive mutants of HSV-1 strain 17. Journal of General Virology 31:347–372
    [Google Scholar]
  19. Moyer S. A., Banerjee A. K. 1975; Messenger RNA species synthesised in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell 4:37–43
    [Google Scholar]
  20. Moyer S. A., Grubman M. J., Ehrenfeld E., Banerjee A. K. 1975; Studies on the in vivo and in vitro messenger RNA species of vesicular stomatitis virus. Virology 67:463–473
    [Google Scholar]
  21. Mukherjee P. K., Simpson R. W. 1987; Transcriptionally defective nucleocapsids of vesicular stomatitis virus from cells treated with indomethacin. Virology 156:25–31
    [Google Scholar]
  22. Paterson R. G. 1983 Studies on the RNA and protein species synthesized in cells infected with ts mutants of VSV New Jersey Ph.D. thesis University of Glasgow:
    [Google Scholar]
  23. Poswillo D. E., Roberts G. J. 1981; Topical carbenoxolone for orofacial herpes simplex infection. Lancet ii:143–144
    [Google Scholar]
  24. Rhodes D. P., Abraham S. A., Colonno R. J., Jelnick W., Banerjee A. K. 1977; Characterization of vesicular stomatitis virus mRNA species synthesized in vitro. Journal of Virology 21:1205–1112
    [Google Scholar]
  25. Roberts N. B., Taylor W. H. 1980; The actions of carbenoxolone on enzymes and their relation to its therapeutic effect. Scandinavian Journal of Gastroenterology 15: supplement 6511–16
    [Google Scholar]
  26. Simons K., Garoff H. 1980; The budding mechanisms of enveloped animal viruses. Journal of General Virology 50:1–21
    [Google Scholar]
  27. Symons A. M., Parke D. V. 1980; The effects of carbenoxolone on the stability of cellular membranes. Scandinavian Journal of Gastroenterology 15: supplement 653–10
    [Google Scholar]
  28. Szilágyi J. F., Cunningham C. 1991; Identification and characterization of a novel non-infectious herpes simplex virus-related particle. Journal of General Virology 72:661–668
    [Google Scholar]
  29. Tkacz J. S., Lampen J. O. 1975; Tunicamycin inhibition of polyisoprenyl N-acetyl glucosaminyl pyrophosphate formation in calf liver microsomes. Biochemical and Biophysical Research Communications 65:248–257
    [Google Scholar]
  30. Villarreal L. P., Breindl M., Holland J. J. 1976; Determination of molar ratios of vesicular stomatitis virus-induced RNA species in BHK-21 cells. Biochemistry 15:1663–1667
    [Google Scholar]
  31. Wildy P., Russell W. C., Horne R. W. 1960; The morphology of herpes virus. Virology 12:204–222
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-2-397
Loading
/content/journal/jgv/10.1099/0022-1317-73-2-397
Loading

Data & Media loading...

Most cited Most Cited RSS feed